Critical

Delivery-room stabilisation of the extremely preterm infant

Golden-hour resuscitation · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Extremely preterm infants (typically <28 weeks) require meticulous delivery-room care to establish gentle lung aeration, maintain temperature and perfusion and avoid injury, within a structured 'golden hour'. Careful oxygen titration, non-invasive support where possible and thermal protection improve survival and reduce morbidity.

Red flags

  • Hypothermia on admission
  • Persistent bradycardia despite effective ventilation
  • Hyperoxia or wide saturation swings
  • Pneumothorax after positive-pressure ventilation
  • Signs of significant blood loss/hypovolaemia

Assessment

Differential diagnosis

  • Respiratory distress syndrome (surfactant deficiency)
  • Perinatal asphyxia
  • Congenital pneumonia/early-onset sepsis
  • Congenital anomaly affecting resuscitation (e.g. CDH)
  • Pulmonary hypoplasia
  • Air leak from positive-pressure ventilation

Investigations

  • Pre-ductal SpO2 and heart rate from birth (pulse oximetry ± ECG)
  • Early blood gas
  • Blood glucose
  • Chest radiograph after stabilisation (lung disease, line/tube positions)
  • Full blood count, CRP and blood culture
  • Cranial ultrasound in first days

Management

  • Hold an antenatal team briefing, confirm plan of care/viability discussion and prepare equipment before delivery.
  • Consider deferred cord clamping (or cord milking per local policy) if the infant is stable.
  • Immediately place the infant (without drying for the smallest) into a polyethylene bag/wrap and under a radiant warmer; use a hat and warmed humidified gases to prevent hypothermia (target 36.5–37.5°C).
  • Start respiratory support with CPAP/PEEP (e.g. ~5–8 cmH2O) to establish and maintain lung aeration; avoid routine intubation if the baby is breathing.
  • Begin resuscitation in a low FiO2 (around 0.21–0.30) and titrate to targeted pre-ductal saturations using an oximeter.
  • If positive-pressure ventilation is required, use controlled inflations with limited peak pressure and PEEP; consider sustained inflation only within trials/protocols.
  • Intubate and give surfactant (or use LISA on CPAP) where indicated by support needs.
  • Avoid hyperoxia and large tidal volumes; monitor response continuously.
  • Maintain glucose, perfusion and avoid rapid fluid boluses unless truly hypovolaemic.
  • Transfer in a transport incubator maintaining temperature and ongoing support.
  • Site umbilical lines under sterile conditions for access and monitoring.
  • Complete the admission, commence caffeine and provide family updates and support.

Drugs & doses

Poractant alfa 200 mg/kg intratracheal (via ETT or LISA) for RDS
Caffeine citrate 20 mg/kg IV loading then 5–10 mg/kg/day
10% dextrose IV infusion to maintain normoglycaemia
Adrenaline 10–30 microgram/kg (0.1–0.3 mL/kg of 1:10,000) IV/IO if HR <60 despite effective ventilation
0.9% sodium chloride 10 mL/kg IV only for proven hypovolaemia/blood loss

Disposition

Deliver and stabilise in a tertiary centre with neonatal intensive care; admit to NICU with full monitoring; arrange in-utero transfer antenatally where possible.

Complications & pitfalls

  • Intraventricular haemorrhage
  • Air leak and lung injury
  • Hypothermia and hypoglycaemia
  • Bronchopulmonary dysplasia
  • Retinopathy of prematurity from oxygen exposure
  • Necrotising enterocolitis

Exam pearls

  • Temperature control is critical – plastic wrap, hat and warm gases from the moment of birth.
  • Start in low oxygen and titrate to pre-ductal saturation targets to avoid hyperoxic injury.
  • Prefer CPAP and non-invasive support; LISA avoids ventilator exposure.
  • Deferred cord clamping improves outcomes when the infant is stable.
  • Gentle aeration with PEEP beats aggressive high-pressure inflation.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.